Praxis Precision Medicines Statistics
Share Statistics
Praxis Precision Medicines has 20.37M
shares outstanding. The number of shares has increased by 17.86%
in one year.
| Shares Outstanding | 20.37M |
| Shares Change (YoY) | 17.86% |
| Shares Change (QoQ) | 8.18% |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 63 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 1.77M, so 8.7% of the outstanding
shares have been sold short.
| Short Interest | 1.77M |
| Short % of Shares Out | 8.7% |
| Short % of Float | 8.72% |
| Short Ratio (days to cover) | 4.18 |
Valuation Ratios
The PE ratio is -7.54 and the forward
PE ratio is -3.31.
Praxis Precision Medicines's PEG ratio is
0.17.
| PE Ratio | -7.54 |
| Forward PE | -3.31 |
| PS Ratio | 161.13 |
| Forward PS | 1.7 |
| PB Ratio | 3.09 |
| P/FCF Ratio | -10.46 |
| PEG Ratio | 0.17 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Praxis Precision Medicines.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.77,
with a Debt / Equity ratio of 0.
| Current Ratio | 10.77 |
| Quick Ratio | 10.77 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $73,732.76 |
| Profits Per Employee | $-1,576,025.86 |
| Employee Count | 116 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -14.79% in the
last 52 weeks. The beta is 2.67, so Praxis Precision Medicines's
price volatility has been higher than the market average.
| Beta | 2.67 |
| 52-Week Price Change | -14.79% |
| 50-Day Moving Average | 36.03 |
| 200-Day Moving Average | 59.17 |
| Relative Strength Index (RSI) | 50.14 |
| Average Volume (20 Days) | 528,466 |
Income Statement
In the last 12 months, Praxis Precision Medicines had revenue of 8.55M
and earned -182.82M
in profits. Earnings per share was -10.21.
| Revenue | 8.55M |
| Gross Profit | 8.2M |
| Operating Income | -200.16M |
| Net Income | -182.82M |
| EBITDA | -200.16M |
| EBIT | -200.16M |
| Earnings Per Share (EPS) | -10.21 |
Full Income StatementBalance Sheet
The company has 215.37M in cash and 1.37M in
debt, giving a net cash position of 214M.
| Cash & Cash Equivalents | 215.37M |
| Total Debt | 1.37M |
| Net Cash | 214M |
| Retained Earnings | -836.74M |
| Total Assets | 478.74M |
| Working Capital | 294.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -131.76M
and capital expenditures 0, giving a free cash flow of -131.76M.
| Operating Cash Flow | -131.76M |
| Capital Expenditures | n/a |
| Free Cash Flow | -131.76M |
| FCF Per Share | -7.36 |
Full Cash Flow StatementMargins
Gross margin is 95.81%, with operating and profit margins of -2340.29% and -2137.48%.
| Gross Margin | 95.81% |
| Operating Margin | -2340.29% |
| Pretax Margin | -2137.48% |
| Profit Margin | -2137.48% |
| EBITDA Margin | -2340.29% |
| EBIT Margin | -2340.29% |
| FCF Margin | -1540.48% |
